{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:27:16Z","timestamp":1794320836970,"version":"4.9.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T00:00:00Z","timestamp":1612051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T00:00:00Z","timestamp":1612051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mucopolysaccharidosis type I-Hurler syndrome (MPSI-H) is a lysosomal storage disease characterized by severe physical symptoms and cognitive decline. Early treatment with hematopoietic cell transplant (HSCT) is critical to the survival of these patients. While survival rates and short-term outcomes are known to be improved by HSCT, the long-term cognitive, adaptive and psychosocial functional outcomes of children with (MPSI-H) post-HSCT are not well documented. This manuscript focuses on retrospective long-term follow-up (7\u201333\u00a0years) of 25 MPSI-H patients, transplanted between 1986 and 2011.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The median age at transplantation was 21\u00a0months (range 12\u201357\u00a0months). Except for one death, all successfully transplanted MPSI-H patients surviving at least 1\u00a0year after HSCT are alive to-date, with a median age of 21\u00a0years (range 8\u201336\u00a0years) at the last follow-up evaluation. A majority of HSCT grafts were bone marrow transplants (BMT), resulting in durable full chimerism in 18 (72%). Pre-HSCT, the onset of first symptoms occurred very early, at a median age of 3\u00a0months (range birth-16\u00a0months). The most prevalent symptoms before MPSI-H diagnosis involved progressive dysostosis multiplex; almost all patients suffered from hip dysplasia and thoracolumbar spine Kyphosis. Despite HSCT, considerable residual disease burden and ensuing corrective surgical interventions were observed in all, and at every decade of follow-up post HSCT. Late-onset psychiatric manifestations were significant (n\u2009=\u200917 patients; 68%), including depression in 13 patients at a median onset age of 18\u00a0years (range 13\u201331\u00a0years), hyperactivity and attention deficit disorder (n\u2009=\u20094), and multiple acute psychotic episodes (APE), independent of depression observed (n\u2009=\u20093) at a median onset age of 18\u00a0years (range 17\u201331\u00a0years). The adult Welscher Intelligence Scale results (n\u2009=\u200916) were heterogenous across the four scale dimensions; overall lower scores were observed on both working memory index (median WMI\u2009=\u200969.5) and processing speed index (median PSI\u2009=\u200965), whereas verbal comprehension index (median VCI\u2009=\u200979) and perceptual reasoning index (median PRI\u2009=\u200974) were higher.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>With advanced treatment options, MPSI-H are living into 3rd and 4th decades of life, however not disease free and with poor adaptation. Residual disease (loss of mobility, limited gross and fine motor skills; low cognitive ability; suboptimal cardiopulmonary function, vision and hearing) negatively impacts the quality of life and psychosocial functioning of affected individuals.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-020-01644-w","type":"journal-article","created":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T08:02:26Z","timestamp":1612080146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Long term disease burden post-transplantation: three decades of observations in 25 Hurler patients successfully treated with hematopoietic stem cell transplantation (HSCT)"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3052-2366","authenticated-orcid":false,"given":"N.","family":"Guffon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pettazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Pangaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Garin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lina-Granade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Plault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mottolese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Froissart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fouilhoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,31]]},"reference":[{"issue":"1","key":"1644_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1542\/peds.2008-0416","volume":"123","author":"J Muenzer","year":"2009","unstructured":"Muenzer J, Wraith JE, Clarke LA. International Consensus Panel on Management and Treatment of Mucopolysaccharidosis I. Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics. 2009;123(1):19\u201329. https:\/\/doi.org\/10.1542\/peds.2008-0416.","journal-title":"Pediatrics"},{"key":"1644_CR2","doi-asserted-by":"publisher","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","volume":"50","author":"J Muenzer","year":"2011","unstructured":"Muenzer J. Overview of the mucopolysaccharidoses. Rheumatology. 2011;50:v4\u201312. https:\/\/doi.org\/10.1093\/rheumatology\/ker394.","journal-title":"Rheumatology"},{"issue":"10","key":"1644_CR3","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/gim.2014.25","volume":"16","author":"M Beck","year":"2014","unstructured":"Beck M, Arn P, Giugliani R, et al. The natural history of MPS I: global perspectives from the MPS I Registry. Genet Med. 2014;16(10):759\u201365. https:\/\/doi.org\/10.1038\/gim.2014.25.","journal-title":"Genet Med"},{"issue":"3","key":"1644_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1750-1172-3-24","volume":"16","author":"D Moore","year":"2008","unstructured":"Moore D, Connock MJ, Wraith E, Lavery C. The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler\u2013Scheie and Scheie syndromes in the UK. Orphanet J Rare Dis. 2008;16(3):24. https:\/\/doi.org\/10.1186\/1750-1172-3-24.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"1644_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/cge.13583","volume":"96","author":"LA Clarke","year":"2019","unstructured":"Clarke LA, Giugliani R, Guffon N, et al. Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): insights from the International MPS I Registry. Clin Genet. 2019;96(4):281\u20139. https:\/\/doi.org\/10.1111\/cge.13583.","journal-title":"Clin Genet"},{"key":"1644_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0022-3476(98)70201-X","volume":"133","author":"N Guffon","year":"1998","unstructured":"Guffon N, Souillet G, Maire I, Straczek J, Guibaud P. Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr. 1998;133:119\u201325.","journal-title":"J Pediatr"},{"issue":"12","key":"1644_CR7","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/sj.bmt.1704105","volume":"31","author":"G Souillet","year":"2003","unstructured":"Souillet G, Guffon N, Maire I, Pujol M, et al. Outcome of 27 patients with Hurler\u2019s syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transplant. 2003;31(12):1105\u201317.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"1644_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ymgme.2014.12.001","volume":"114","author":"S Tomatsu","year":"2015","unstructured":"Tomatsu S, Alm\u00e9ciga-D\u00edaz CJ, Monta\u00f1o AM, et al. Therapies for the bone in mucopolysaccharidoses. Mol Genet Metab. 2015;114(2):94\u2013109. https:\/\/doi.org\/10.1016\/j.ymgme.2014.12.001.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"1644_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/adc.72.3.263","volume":"72","author":"JE Wraith","year":"1995","unstructured":"Wraith JE. The mucopolysaccharidoses: a clinical review and guide to management. Arch Dis Child. 1995;72(3):263\u20137. https:\/\/doi.org\/10.1136\/adc.72.3.263.","journal-title":"Arch Dis Child"},{"issue":"19","key":"1644_CR10","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1056\/NEJMoa032613","volume":"350","author":"SL Staba","year":"2004","unstructured":"Staba SL, Escolar ML, Poe M, Kim Y, et al. Cord-blood transplants from unrelated donors in patients with Hurler\u2019s syndrome. N Engl J Med. 2004;350(19):1960\u20139.","journal-title":"N Engl J Med"},{"issue":"19","key":"1644_CR11","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1182\/blood-2012-09-455238","volume":"121","author":"JJ Boelens","year":"2013","unstructured":"Boelens JJ, Aldenhoven M, Purtill D, Ruggeri A, et al. Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. Blood. 2013;121(19):3981\u20137. https:\/\/doi.org\/10.1182\/blood-2012-09-455238.","journal-title":"Blood"},{"issue":"7","key":"1644_CR12","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1182\/blood.V91.7.2601","volume":"91","author":"C Peters","year":"1998","unstructured":"Peters C, Shapiro EG, Anderson J, Henslee-Downey PJ, et al. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood. 1998;91(7):2601\u20138.","journal-title":"Blood"},{"issue":"7","key":"1644_CR13","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1016\/j.bbmt.2019.02.012","volume":"25","author":"M Taylor","year":"2019","unstructured":"Taylor M, Khan S, Stapleton M, et al. Hematopoietic stem cell transplantation for mucopolysaccharidoses: past, present, and future. Biol Blood Marrow Transplant. 2019;25(7):e226\u201346. https:\/\/doi.org\/10.1016\/j.bbmt.2019.02.012.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1644_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1750-1172-6-55","volume":"6","author":"MH de Ru","year":"2011","unstructured":"de Ru MH, Boelens JJ, Das AM, et al. Enzyme replacement therapy and, or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis. 2011;6:55. https:\/\/doi.org\/10.1186\/1750-1172-6-55.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"1644_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ymgme.2006.08.007","volume":"90","author":"M Sifuentes","year":"2007","unstructured":"Sifuentes M, Doroshow R, Hoft R, Mason G, et al. A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. Mol Genet Metab. 2007;90(2):171\u201380. https:\/\/doi.org\/10.1016\/j.ymgme.2006.08.007.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"1644_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ymgme.2016.01.011","volume":"117","author":"A Ghosh","year":"2016","unstructured":"Ghosh A, Miller W, Orchard PJ, Jones SA, et al. Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10-year combined experience of 2 centres. Mol Genet Metab. 2016;117(3):373\u20137. https:\/\/doi.org\/10.1016\/j.ymgme.2016.01.011.","journal-title":"Mol Genet Metab"},{"issue":"1\u20132","key":"1644_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ymgme.2015.06.002","volume":"116","author":"EG Shapiro","year":"2015","unstructured":"Shapiro EG, Nestrasil I, Rudser K, et al. Neurocognition across the spectrum of mucopolysaccharidosis type I: age, severity, and treatment. Mol Genet Metab. 2015;116(1\u20132):61\u20138. https:\/\/doi.org\/10.1016\/j.ymgme.2015.06.002.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"1644_CR18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jpeds.2012.07.052","volume":"162","author":"JB Eisengart","year":"2013","unstructured":"Eisengart JB, Rudser KD, Tolar J, Orchard PJ, et al. Enzyme replacement is associated with better cognitive outcomes after transplant in Hurler syndrome. J Pediatr. 2013;162(2):375-80.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2012.07.052.","journal-title":"J Pediatr"},{"issue":"13","key":"1644_CR19","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1182\/blood-2014-11-608075","volume":"125","author":"M Aldenhoven","year":"2015","unstructured":"Aldenhoven M, Wynn RF, Orchard PJ, O\u2019Meara A, et al. Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study. Blood. 2015;125(13):2164\u201372. https:\/\/doi.org\/10.1182\/blood-2014-11-608075.","journal-title":"Blood"},{"issue":"1","key":"1644_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/sj.bmt.1705401","volume":"38","author":"J Cox-Brinkman","year":"2006","unstructured":"Cox-Brinkman J, Boelens JJ, Wraith JE, O\u2019meara A, et al. Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome. Bone Marrow Transplant. 2006;38(1):17\u201321.","journal-title":"Bone Marrow Transplant"},{"key":"1644_CR21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/ana.24246","volume":"76","author":"MD Poe","year":"2014","unstructured":"Poe MD, Chagnon SL, Escolar ML. Early treatment is associated with improved cognition in hurler syndrome. Ann Neurol. 2014;76:747\u201353. https:\/\/doi.org\/10.1002\/ana.24246.","journal-title":"Ann Neurol"},{"issue":"1","key":"1644_CR22","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13023-017-0662-9","volume":"12","author":"R Parini","year":"2017","unstructured":"Parini R, Deodato F, Di Rocco M, Lanino E, et al. Open issues in Mucopolysaccharidosis type I-Hurler. Orphanet J Rare Dis. 2017;12(1):112. https:\/\/doi.org\/10.1186\/s13023-017-0662-9.","journal-title":"Orphanet J Rare Dis"},{"key":"1644_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ymgmr.2014.12.006","volume":"2","author":"E Yasuda","year":"2015","unstructured":"Yasuda E, Mackenzie W, Ruhnke K, Shimada T, et al. Molecular Genetics and Metabolism Report Long-term follow-up of post hematopoietic stem cell transplantation for Hurler syndrome: clinical, biochemical, and pathological improvements. Mol Genet Metab Rep. 2015;2:65\u201376.","journal-title":"Mol Genet Metab Rep"},{"issue":"6","key":"1644_CR24","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.bbmt.2015.02.011","volume":"21","author":"M Aldenhoven","year":"2015","unstructured":"Aldenhoven M, Jones SA, Bonney D, et al. Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines. Biol Blood Marrow Transplant. 2015;21(6):1106\u20139. https:\/\/doi.org\/10.1016\/j.bbmt.2015.02.011.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"1644_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1053\/j.seminhematol.2009.10.008","volume":"47","author":"VK Prasad","year":"2010","unstructured":"Prasad VK, Kurtzberg J. Transplant outcomes in mucopolysaccharidoses. Semin Hematol. 2010;47(1):59\u201369. https:\/\/doi.org\/10.1053\/j.seminhematol.2009.10.008.","journal-title":"Semin Hematol"},{"issue":"3","key":"1644_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10545-011-9304-x","volume":"34","author":"MH van der Linden","year":"2011","unstructured":"van der Linden MH, Kruyt MC, Sakkers RJ, de Koning TJ, et al. Orthopaedic management of Hurler\u2019s disease after hematopoietic stem cell transplantation: a systematic review. J Inherit Metab Dis. 2011;34(3):657\u201369. https:\/\/doi.org\/10.1007\/s10545-011-9304-x.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"1644_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13023-018-0817-3","volume":"13","author":"EG Shapiro","year":"2018","unstructured":"Shapiro EG, Whitley CB, Eisengart JB. Beneath the floor: re-analysis of neurodevelopmental outcomes in untreated Hurler syndrome. Orphanet J Rare Dis. 2018;13(1):76. https:\/\/doi.org\/10.1186\/s13023-018-0817-3.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"1644_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.bbmt.2008.01.009","volume":"14","author":"M Aldenhoven","year":"2008","unstructured":"Aldenhoven M, Boelens JJ, de Koning TJ. The clinical outcome of Hurler syndrome after stem cell transplantation. Biol Blood Marrow Transplant. 2008;14(5):485\u201398. https:\/\/doi.org\/10.1016\/j.bbmt.2008.01.009.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1644_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-019-0541-2","author":"LE Polgreen","year":"2019","unstructured":"Polgreen LE, Lund TC, Braunlin E, Tolar J, et al. Clinical trial of laronidase in Hurler syndrome after hematopoietic cell transplantation. Pediatr Res. 2019. https:\/\/doi.org\/10.1038\/s41390-019-0541-2.","journal-title":"Pediatr Res"},{"key":"1644_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/1750-1172-8-155","volume":"8","author":"EJ Langereis","year":"2013","unstructured":"Langereis EJ, Borgo A, Crushell E, Harmatz PR, et al. Treatment of hip dysplasia in patients with mucopolysaccharidosis type I after hematopoietic stem cell transplantation: results of an international consensus procedure. Orphanet J Rare Dis. 2013;8:155. https:\/\/doi.org\/10.1186\/1750-1172-8-155.","journal-title":"Orphanet J Rare Dis"},{"key":"1644_CR31","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.exer.2016.05.022","volume":"148","author":"C Yuan","year":"2016","unstructured":"Yuan C, Bothun ED, Hardten DR, Tolar J, McLoon LK. A novel explanation of corneal clouding in a bone marrow transplant-treated patient with Hurler syndrome. Exp Eye Res. 2016;148:83\u20139. https:\/\/doi.org\/10.1016\/j.exer.2016.05.022.","journal-title":"Exp Eye Res"},{"key":"1644_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12277","author":"BTA van den Broek","year":"2020","unstructured":"van den Broek BTA, Smit AL, Boelens JJ, van Hasselt PM. Hearing loss in patients with mucopolysaccharidoses-1 and -6 after hematopoietic cell transplantation: a longitudinal analysis [published online ahead of print, 2020 Jun 24]. J Inherit Metab Dis. 2020. https:\/\/doi.org\/10.1002\/jimd.12277.","journal-title":"J Inherit Metab Dis"},{"key":"1644_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2018.29","author":"JB Eisengart","year":"2018","unstructured":"Eisengart JB, Rudser KD, Xue Y, Orchard P, et al. Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison. Genet Med. 2018. https:\/\/doi.org\/10.1038\/gim.2018.29.","journal-title":"Genet Med"},{"issue":"2","key":"1644_CR34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/adc.76.2.92","volume":"76","author":"A Vellodi","year":"1997","unstructured":"Vellodi A, Young EP, Cooper A, Wraith JE, et al. Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres. Arch Dis Child. 1997;76(2):92\u20139.","journal-title":"Arch Dis Child"},{"key":"1644_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ymgme.2017.09.010","volume":"122","author":"ML Escolar","year":"2017","unstructured":"Escolar ML, Jones SA, Shapiro EG, Horovitz DDG, et al. Practical management of behavioral problems in mucopolysaccharidoses disorders. Mol Genet Metab. 2017;122:35\u201340. https:\/\/doi.org\/10.1016\/j.ymgme.2017.09.010.","journal-title":"Mol Genet Metab"},{"key":"1644_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/8904_2017_47","volume":"39","author":"A Lehtonen","year":"2018","unstructured":"Lehtonen A, Rust S, Jones S, Brown R, Hare D. Social functioning and behaviour in mucopolysaccharidosis IH [Hurlers syndrome]. JIMD Rep. 2018;39:75\u201381. https:\/\/doi.org\/10.1007\/8904_2017_47.","journal-title":"JIMD Rep"},{"key":"1644_CR37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13023-016-0478-z","volume":"11","author":"A Soni-Jaiswal","year":"2016","unstructured":"Soni-Jaiswal A, Mercer J, Jones SA, Bruce IA, Callery P. Mucopolysaccharidosis I; Parental beliefs about the impact of disease on the quality of life of their children. Orphanet J Rare Dis. 2016;11:96. https:\/\/doi.org\/10.1186\/s13023-016-0478-z.","journal-title":"Orphanet J Rare Dis"},{"key":"1644_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/8904_2015_521","volume":"29","author":"AS Kunin-Batson","year":"2016","unstructured":"Kunin-Batson AS, Shapiro EG, Rudser KD, Lavery CA, et al. Long-term cognitive and functional outcomes in children with mucopolysaccharidosis (MPS)-IH (Hurler syndrome) treated with hematopoietic cell transplantation. JIMD Rep. 2016;29:95\u2013102.","journal-title":"JIMD Rep"},{"key":"1644_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ymgme.2017.09.007","volume":"122S","author":"EG Shapiro","year":"2017","unstructured":"Shapiro EG, Escolar ML, Delaney KA, Mitchell JJ. Assessments of neurocognitive and behavioral function in the mucopolysaccharidoses. Mol Genet Metab. 2017;122S:8\u201316. https:\/\/doi.org\/10.1016\/j.ymgme.2017.09.007.","journal-title":"Mol Genet Metab"},{"key":"1644_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymgme.2017.08.009","volume":"122S","author":"EG Shapiro","year":"2017","unstructured":"Shapiro EG, Jones SA, Escolar ML. Developmental and behavioral aspects of mucopolysaccharidoses with brain manifestations\u2014neurological signs and symptoms. Mol Genet Metab. 2017;122S:1\u20137. https:\/\/doi.org\/10.1016\/j.ymgme.2017.08.009.","journal-title":"Mol Genet Metab"},{"issue":"24","key":"1644_CR41","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1182\/bloodadvances.2017011387","volume":"1","author":"M Aldenhoven","year":"2017","unstructured":"Aldenhoven M, van den Broek BTA, Wynn RF, O\u2019Meara A, et al. Quality of life of Hurler syndrome patients after successful hematopoietic stem cell transplantation. Blood Adv. 2017;1(24):2236\u201342. https:\/\/doi.org\/10.1182\/bloodadvances.2017011387.","journal-title":"Blood Adv"},{"key":"1644_CR42","doi-asserted-by":"publisher","unstructured":"Kubaski F, de Oliveira Poswar F, Michelin-Tirelli K, Matte UDS, et al. Mucopolysaccharidosis Type I. Diagnostics (Basel). 2020;10(3):161. https:\/\/doi.org\/10.3390\/diagnostics10030161.","DOI":"10.3390\/diagnostics10030161"},{"key":"1644_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ana.1098","volume":"50","author":"T Seto","year":"2001","unstructured":"Seto T, Kono K, Morimoto K, Inoue Y, et al. Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation. Ann Neurol. 2001;50:79\u201392.","journal-title":"Ann Neurol"},{"key":"1644_CR44","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s10545-011-9359-8","volume":"34","author":"EA Braunlin","year":"2011","unstructured":"Braunlin EA, Harmatz PR, Scarpa M, Furlanetto B, et al. Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J Inherit Metab Dis. 2011;34:1183\u201397. https:\/\/doi.org\/10.1007\/s10545-011-9359-8.","journal-title":"J Inherit Metab Dis"},{"key":"1644_CR45","doi-asserted-by":"publisher","DOI":"10.1517\/21678707.2016.1147948","author":"SH Lum","year":"2016","unstructured":"Lum SH, Jones SA, Ghosh A, Bigger BW, Wynn RF. Hematopoietic stem cell transplant for the mucopolysaccharidoses. Expert Opin Orphan Drugs. 2016. https:\/\/doi.org\/10.1517\/21678707.2016.1147948.","journal-title":"Expert Opin Orphan Drugs"},{"issue":"3","key":"1644_CR46","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10545-017-0034-6","volume":"40","author":"SH Lum","year":"2017","unstructured":"Lum SH, Stepien KM, Ghosh A, Broomfield A, Church H, Mercer J, Jones S, Wynn R. Long term survival and cardiopulmonary outcome in children with Hurler syndrome after haematopoietic stem cell transplantation. J Inherit Metab Dis. 2017;40(3):455\u201360. https:\/\/doi.org\/10.1007\/s10545-017-0034-6.","journal-title":"J Inherit Metab Dis."},{"issue":"9","key":"1644_CR47","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/gim.2016.223","volume":"19","author":"SD Grosse","year":"2017","unstructured":"Grosse SD, Lam WKK, Wiggins LD, Kemper AR. Cognitive outcomes and age of detection of severe mucopolysaccharidosis type 1. Genet Med. 2017;19(9):975\u201382. https:\/\/doi.org\/10.1038\/gim.2016.223.","journal-title":"Genet Med"},{"issue":"3","key":"1644_CR48","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1517\/21678707.2015.1016908","volume":"3","author":"EJ Langereis","year":"2015","unstructured":"Langereis EJ, van Vlies N, Wijburg FA. Diagnosis, classification and treatment of mucopolysaccharidosis type I. Expert Opin Orphan Drugs. 2015;3(3):307\u201320. https:\/\/doi.org\/10.1517\/21678707.2015.1016908.","journal-title":"Expert Opin Orphan Drugs"},{"key":"1644_CR49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/8904_2014_395","volume":"20","author":"HY Coletti","year":"2015","unstructured":"Coletti HY, Aldenhoven M, Yelin K, Poe MD, et al. Long-term functional outcomes of children with Hurler syndrome treated with unrelated umbilical cord blood transplantation. JIMD Rep. 2015;20:77\u201386. https:\/\/doi.org\/10.1007\/8904_2014_395.","journal-title":"JIMD Rep"},{"issue":"1","key":"1644_CR50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13023-017-0583-7","volume":"12","author":"BT Kiely","year":"2017","unstructured":"Kiely BT, Kohler JL, Coletti HY, Poe MD, Escolar ML. Early disease progression of Hurler syndrome. Orphanet J Rare Dis. 2017;12(1):32. https:\/\/doi.org\/10.1186\/s13023-017-0583-7.","journal-title":"Orphanet J Rare Dis"},{"issue":"1\u20132","key":"1644_CR51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ymgme.2012.07.016","volume":"107","author":"E Shapiro","year":"2012","unstructured":"Shapiro E, Guler OE, Rudser K, Delaney K, et al. An exploratory study of brain function and structure in mucopolysaccharidosis type I: long term observations following hematopoietic cell transplantation (HCT). Mol Genet Metab. 2012;107(1\u20132):116\u201321. https:\/\/doi.org\/10.1016\/j.ymgme.2012.07.016.","journal-title":"Mol Genet Metab"},{"issue":"1\u20132","key":"1644_CR52","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ymgme.2017.05.009","volume":"122","author":"GA Kuiper","year":"2017","unstructured":"Kuiper GA, van Hasselt PM, Boelens JJ, Wijburg FA, Langereis EJ. Incomplete biomarker response in mucopolysaccharidosis type I after successful hematopoietic cell transplantation. Mol Genet Metab. 2017;122(1\u20132):86\u201391. https:\/\/doi.org\/10.1016\/j.ymgme.2017.05.009.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"1644_CR53","doi-asserted-by":"publisher","first-page":"14105","DOI":"10.1038\/s41598-019-50595-1","volume":"9","author":"TC Lund","year":"2019","unstructured":"Lund TC, Miller WP, Liao AY, Tolar J, et al. Post-transplant laronidase augmentation for children with Hurler syndrome: biochemical outcomes. Sci Rep. 2019;9(1):14105. https:\/\/doi.org\/10.1038\/s41598-019-50595-1.","journal-title":"Sci Rep"},{"issue":"5","key":"1644_CR54","doi-asserted-by":"publisher","first-page":"e1242","DOI":"10.1542\/peds.2009-2843","volume":"126","author":"V Valayannopoulos","year":"2010","unstructured":"Valayannopoulos V, de Blic J, Mahlaoui N, et al. Laronidase for cardiopulmonary disease in Hurler syndrome 12 years after bone marrow transplantation. Pediatrics. 2010;126(5):e1242\u20137. https:\/\/doi.org\/10.1542\/peds.2009-2843.","journal-title":"Pediatrics"},{"key":"1644_CR55","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/8904_2012_175","volume":"9","author":"FJ Stoop","year":"2013","unstructured":"Stoop FJ, Kruyt MC, van der Linden MH, Sakkers RJB, et al. Prevalence and development of orthopaedic symptoms in the Dutch Hurler patient population after haematopoietic stem cell transplantation. JIMD Rep. 2013;9:17\u201329. https:\/\/doi.org\/10.1007\/8904_2012_175.","journal-title":"JIMD Rep"},{"issue":"5","key":"1644_CR56","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/aos.13627","volume":"96","author":"A Javed","year":"2018","unstructured":"Javed A, Aslam T, Jones SA, Mercer J, Tyler K, Church H, Ghosh A, Wynn R, Sornalingam K, Ashworth J. The effect of haemopoietic stem cell transplantation on the ocular phenotype in mucopolysaccharidosis type I (Hurler). Acta Ophthalmol. 2018;96(5):494\u20138. https:\/\/doi.org\/10.1111\/aos.13627.","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"1644_CR57","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00004694-200401000-00019","volume":"24","author":"JS Weisstein","year":"2004","unstructured":"Weisstein JS, Delgado E, Steinbach LS, Hart K, Packman S. Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantation. J Pediatr Orthop. 2004;24(1):97\u2013101. https:\/\/doi.org\/10.1097\/00004694-200401000-00019.","journal-title":"J Pediatr Orthop."},{"issue":"1","key":"1644_CR58","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13023-016-0470-7","volume":"11","author":"M Schmidt","year":"2016","unstructured":"Schmidt M, Breyer S, L\u00f6bel U, Yarar S, et al. Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation. Orphanet J Rare Dis. 2016;11(1):93. https:\/\/doi.org\/10.1186\/s13023-016-0470-7.","journal-title":"Orphanet J Rare Dis"},{"key":"1644_CR59","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13023-019-0997-5","volume":"14","author":"GA Kuiper","year":"2019","unstructured":"Kuiper GA, Langereis EJ, Breyer S, Carbone M, et al. Treatment of thoracolumbar kyphosis in patients with mucopolysaccharidosis type I: results of an international consensus procedure. Orphanet J Rare Dis. 2019;14:17. https:\/\/doi.org\/10.1186\/s13023-019-0997-5.","journal-title":"Orphanet J Rare Dis"},{"key":"1644_CR60","volume-title":"Auxologie m\u00e9thode et s\u00e9quences Th\u00e9raplix","author":"M Semp\u00e9","year":"1997","unstructured":"Semp\u00e9 M, P\u00e9dron G, Roy-Pernot M-P. Auxologie m\u00e9thode et s\u00e9quences Th\u00e9raplix. Paris: M\u00e9ditions; 1997."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01644-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-020-01644-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01644-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,31]],"date-time":"2021-01-31T08:02:28Z","timestamp":1612080148000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01644-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,31]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1644"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01644-w","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,31]]},"assertion":[{"value":"24 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No ethics committee approval was required for this work","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and consent to participate"}},{"value":"All families have been informed and agreed for this publication of history and data. No images and video of patients included into this work","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to report","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}